A perspective on why many AI tools fall short in drug development — and what it takes to build tools that deliver real value.

A podcast discussion with Pauric Bannigan, CSO, on reinventing drug formulation through AI, automation, and self-driving labs.

A demonstration of a closed-loop autonomous system that combines an agentic AI pipeline with a miniaturized robotic laboratory to discover novel drug formulations.

Quotient Sciences advances an AI-designed drug product into clinical development using Intrepid Labs’ machine learning technology.

An article on using predictive modeling to support small-molecule formulation development.

An article highlighting Intrepid and Quotient’s partnership to accelerate drug development with artificial intelligence.

Intrepid Labs received Life Sciences Review Magazine’s “Top Machine Learning Based Drug Development Company in Canada 2026” award, and was named among “Top Drug Discovery and Development Companies in Canada".

Intrepid Labs was featured in the AI-era data infrastructure market map.

Christine Allen, CEO, shares how drug delivery innovation can help restore the balance between breakthrough science and real-world impact.

A discussion on human-centric AI and accelerating formulation development without compromising trust.

Intrepid Labs is featured among Toronto innovations changing the world through science, technology, and AI.

An article discussing how Intrepid Labs found the perfect home for its headquarters.

A feature on how artificial intelligence is shaping the future of drug discovery, development, and delivery.

An evaluation of how large language models can use structured formulation data and in-context learning to predict key SEDDS properties without model retraining.

An article exploring the blueprint for formulation success using automation and AI.

AVANT BIO was nominated by the prestigious Galien Foundation for the Prix Galien Award in the "Incubators, Accelerators and Equity" category.

Intrepid Labs was named among the 2025 Prix Galien USA Best Startup nominees, recognizing innovation in life sciences.

An article on Intrepid Labs’ $11 million raise and its AI- and robotics-enabled approach to developing customized formulations for new and existing medicines.

This article highlights Intrepid Labs’ work using AI and automation to improve pharmaceutical formulation development.

Intrepid Labs emerges from stealth with $11M in funding to advance AI- and robotics-powered drug formulation.

A profile on Dr. Christine Allen and Intrepid Labs’ work to accelerate drug development with AI.

How Intrepid Labs is using AI, automation, and formulation science to build better medicines faster.

A look at how Intrepid Labs’ autonomous lab approach is changing traditional formulation workflows.

Propagator Ventures shares why it invested in Intrepid Labs and its AI-powered formulation platform.

A podcast featuring Christine Allen, CEO, on how AI-driven innovation can create meaningful impact in health and medicine.

A media segment exploring how AI is changing the future of cancer treatment and drug development.

A proposed framework combining high-throughput experimentation, artificial intelligence, and shared data to accelerate nanomedicine development.

A study demonstrating the use of machine learning to predict drug release and guide the design of new polymeric long-acting injectable formulations.

A review highlighting the potential of machine learning to accelerate formulation development, uncover new knowledge in drug formulation science, and enable emerging workflows such as self-driving laboratories.

A perspective on how AI-driven prediction could streamline formulation development and support faster, more informed decision-making.